| 000 | 01386 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513175936.0 | ||
| 264 | 0 | _c19990615 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaylor, A A | |
| 245 | 0 | 0 |
_aSustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cMay 1999 |
||
| 300 |
_a471-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aDopamine Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenoldopam _xadministration & dosage |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 700 | 1 | _aMangoo-Karim, R | |
| 700 | 1 | _aBallard, K D | |
| 700 | 1 | _aLuther, R R | |
| 700 | 1 | _aPool, J L | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 39 _gno. 5 _gp. 471-9 |
|
| 999 |
_c10193536 _d10193536 |
||